AU2001278003A1 - Bacteriophage having multiple host range - Google Patents
Bacteriophage having multiple host rangeInfo
- Publication number
- AU2001278003A1 AU2001278003A1 AU2001278003A AU7800301A AU2001278003A1 AU 2001278003 A1 AU2001278003 A1 AU 2001278003A1 AU 2001278003 A AU2001278003 A AU 2001278003A AU 7800301 A AU7800301 A AU 7800301A AU 2001278003 A1 AU2001278003 A1 AU 2001278003A1
- Authority
- AU
- Australia
- Prior art keywords
- bacteriophage
- host range
- multiple host
- prophylaxis
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/14011—Details ssDNA Bacteriophages
- C12N2795/14211—Microviridae
- C12N2795/14232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/948—Microorganisms using viruses or cell lines
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Toys (AREA)
- Feedback Control In General (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22098700P | 2000-07-25 | 2000-07-25 | |
US60/220,987 | 2000-07-25 | ||
PCT/US2001/023390 WO2002007742A2 (en) | 2000-07-25 | 2001-07-25 | Bacteriophage having multiple host range |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001278003A1 true AU2001278003A1 (en) | 2002-02-05 |
Family
ID=22825862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001278003A Abandoned AU2001278003A1 (en) | 2000-07-25 | 2001-07-25 | Bacteriophage having multiple host range |
Country Status (8)
Country | Link |
---|---|
US (1) | US7163818B2 (de) |
EP (1) | EP1305038B1 (de) |
AT (1) | ATE305793T1 (de) |
AU (1) | AU2001278003A1 (de) |
CA (1) | CA2417188A1 (de) |
DE (1) | DE60113851T2 (de) |
ES (1) | ES2252263T3 (de) |
WO (1) | WO2002007742A2 (de) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000508322A (ja) * | 1996-04-15 | 2000-07-04 | エヌワイエムオーエックス コーポレーション | バクテリオファージを含有する組成物および感染症を治療するためのバクテリオファージの使用方法 |
DE60231168D1 (de) | 2001-06-15 | 2009-04-02 | Prysmian Cables & Systems Ltd | Verbinden optischer Fasern |
EA007472B1 (ru) * | 2001-07-18 | 2006-10-27 | Институт Иммунологии И Терапии Досвядчальней Пан | Поливалентные штаммы бактериофага, способы их получения и использования и содержащее указанные штаммы лекарственное средство |
GB0209680D0 (en) * | 2002-04-27 | 2002-06-05 | Univ Strathclyde | Immobilisation and stabilisation of bacteriophage |
WO2004052274A2 (en) | 2002-12-09 | 2004-06-24 | Phage Biopharm Llc | Production of bacteriophage compositions for use in phage therapy |
GB0300597D0 (en) | 2003-01-10 | 2003-02-12 | Microbiological Res Authority | Phage biofilms |
US7951579B2 (en) | 2003-04-07 | 2011-05-31 | Board of Trutees of the University of Arkansas | Method for bacteriophage delivery and amplification |
CA2533352C (en) | 2003-07-23 | 2016-01-19 | Biocontrol Limited | Bacteriophage-containing therapeutic agents |
GB0320838D0 (en) | 2003-09-05 | 2003-10-08 | Univ Nottingham | Disinfection of foodstuffs |
US20090191254A1 (en) * | 2004-12-06 | 2009-07-30 | The Govt. Of The U.S.A., Centers For Disease Control And Prevention | Inhibition of biofilm formation using bacteriophage |
WO2006066224A2 (en) * | 2004-12-14 | 2006-06-22 | Yale University | Virulence targeted antibiotics |
CA2495138C (en) * | 2005-01-20 | 2012-10-23 | Alison Jane Basile | Multiplexed analysis for determining a serodiagnosis of viral infection |
EP1855723B1 (de) * | 2005-03-08 | 2013-05-22 | Ramot at Tel-Aviv University Ltd. | Zielgerichtete arzneistofftragende bakteriophagen |
CA2614800C (en) | 2005-07-12 | 2018-10-30 | The University Of Leeds | Bacteriophage specifically for lysing propionibacterium acnes and uses thereof |
WO2007044428A2 (en) * | 2005-10-05 | 2007-04-19 | Internalle, Inc. | Method for liberating bacteriophages and uses thereof |
WO2007113657A1 (en) | 2006-04-04 | 2007-10-11 | Centre National De La Recherche Scientifique - Cnrs | Process of production of bacteriophage compositions and methods in phage therapy field |
KR100781669B1 (ko) * | 2006-06-20 | 2007-12-03 | 주식회사 인트론바이오테크놀로지 | 황색포도상구균 특이적 사멸능을 갖는 박테리오파지 |
KR100759988B1 (ko) * | 2006-08-04 | 2007-09-19 | 주식회사 인트론바이오테크놀로지 | 황색포도상구균에 특이적인 항균 단백질 |
FR2910492B1 (fr) * | 2006-12-20 | 2013-02-15 | Bio Modeling Systems Ou Bmsystems | Procede de preparation de bacteriophages modifies par insertion de sequences aleatoires dans les proteines de ciblage desdits bacteriophages |
FR2910493B1 (fr) * | 2006-12-20 | 2012-12-14 | Bio Modeling Systems Ou Bmsystems | Procede de diversification aleatoire d'une sequence genetique permettant de preserver l'identite de certains segments internes de ladite sequence genetique |
GB0704553D0 (en) | 2007-03-09 | 2007-04-18 | Harper David R | Beneficial effects of bacteriophage treatments |
WO2008121830A2 (en) * | 2007-03-30 | 2008-10-09 | National Research Council Of Canada | Phage receptor binding proteins for antibacterial therapy and other novel uses |
KR100910961B1 (ko) * | 2007-09-13 | 2009-08-05 | 주식회사 인트론바이오테크놀로지 | 황색포도상구균의 균막 처치에 효과적인 박테리오파지 또는그것 유래의 용균단백질 |
US20100092431A1 (en) * | 2008-05-15 | 2010-04-15 | Auburn University | Edwardsiella Ictaluri Bacteriophage and Uses Thereof |
US8377866B2 (en) * | 2009-02-12 | 2013-02-19 | Intron Biotechnology, Inc. | Antimicrobial protein derived from Podoviridae bacteriophage specific to Staphylococcus aureus |
TWI458734B (zh) * | 2011-04-20 | 2014-11-01 | Univ Nat Taiwan | 對克雷伯氏肺炎桿菌(klebsiella pneumoniae)莢膜型菌株具專一性的新穎多肽及噬菌體及其應用 |
WO2013010660A1 (en) * | 2011-07-15 | 2013-01-24 | Medizinische Hochschule Hannover (Mhh) | Enzymes having alpha2,9 endosialidase activity |
RU2518303C2 (ru) * | 2012-06-29 | 2014-06-10 | Федеральное бюджетное учреждение науки "Московский научно-исследовательский институт эпидемиологии и микробиологии имени Г.Н. Габричевского" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН МНИИЭМ им. Г.Н. Габричевского Роспотребнадзора) | КОМПОЗИЦИЯ АНТИБАКТЕРИАЛЬНАЯ, ШТАММ БАКТЕРИОФАГА Escherichia coli, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПОЛУЧЕНИЯ ТАКОЙ КОМПОЗИЦИИ. |
US9617522B2 (en) | 2013-09-05 | 2017-04-11 | Massachusetts Institute Of Technology | Tuning bacteriophage host range |
EP2893933A1 (de) * | 2014-01-10 | 2015-07-15 | Pherecydes Pharma | Phagentherapie von E.coli-Infektionen |
GB201417808D0 (en) * | 2014-10-08 | 2014-11-19 | Phico Therapeutics Ltd | Modified bacteriophage |
GB201417810D0 (en) | 2014-10-08 | 2014-11-19 | Phico Therapeutics Ltd | Modifying bacteriophage |
GB201417811D0 (en) * | 2014-10-08 | 2014-11-19 | Phico Therapeutics Ltd | Modifying bacteriophage |
GB201417805D0 (en) * | 2014-10-08 | 2014-11-19 | Phico Therapeutics Ltd | Modifield bacteriophage |
EP3018201A1 (de) | 2014-11-07 | 2016-05-11 | Pherecydes Pharma | Phagentherapie |
AU2015362618B2 (en) | 2014-12-16 | 2022-01-27 | C3J Therapeutics, Inc. | Compositions of and methods for in vitro viral genome engineering |
LT3440200T (lt) | 2016-04-08 | 2021-05-25 | Phico Therapeutics Ltd | Modifikuotas bakteriofagas |
CA3020371A1 (en) | 2016-04-08 | 2017-10-12 | Phico Therapeutics Ltd. | Modifying bacteriophage |
EP3532850A1 (de) | 2016-10-28 | 2019-09-04 | Massachusetts Institute Of Technology | Synthetische bakteriophagen und bakteriophagenzusammensetzungen |
KR101822812B1 (ko) * | 2017-02-22 | 2018-01-29 | 주식회사 인트론바이오테크놀로지 | 신규한 엔테로코쿠스 패슘 박테리오파지 Ent-FAP-4 및 이의 엔테로코쿠스 패슘 증식 억제 용도 |
US10174295B1 (en) | 2017-08-01 | 2019-01-08 | The Charles Stark Draper Laboratory, Inc. | Composition of matter: engineering of Escherichia coli phage K1E |
GB201712733D0 (en) | 2017-08-08 | 2017-09-20 | Snipr Tech Ltd | Methods & cells |
EP3740570A4 (de) * | 2018-01-19 | 2021-10-13 | Cytophage Technologies Inc. | Genetisch manipulierte bakteriophagen |
GB201901099D0 (en) | 2019-01-27 | 2019-03-13 | Snipr Biome Aps | Methods, uses and compositions |
AU2020312725A1 (en) * | 2019-07-18 | 2022-03-03 | Technische Universität München | Host-independent expression of bacteriophages |
CN112695017B (zh) * | 2019-10-23 | 2022-04-15 | 吉林大学 | 噬菌体vB_Yen_X1及在防治鼠疫杆菌感染中应用 |
US11584781B2 (en) | 2019-12-30 | 2023-02-21 | Eligo Bioscience | Chimeric receptor binding proteins resistant to proteolytic degradation |
CN111876400B (zh) * | 2020-08-06 | 2022-05-24 | 昆明理工大学 | 一种常温裂解酶Sly和编码此酶的多核苷酸 |
CN112143747B (zh) * | 2020-09-09 | 2022-09-13 | 昆明理工大学 | 一种噬菌体裂解酶及其基因、基因重组表达载体与应用 |
CN113215114A (zh) * | 2021-06-09 | 2021-08-06 | 西南石油大学 | 一种ndm-1大肠杆菌噬菌体及其分离方法和应用 |
WO2024003301A1 (en) | 2022-06-29 | 2024-01-04 | Snipr Biome Aps | Targeting e coli cells |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4405720A (en) * | 1981-03-04 | 1983-09-20 | The United States Of America As Represented By The Department Of Health And Human Services | Silver stains for protein in gels |
US4508820A (en) * | 1982-08-13 | 1985-04-02 | The United States Of America As Represented By The Department Of Health And Human Services | Method for simultaneously monitoring turnover rate in multiple proteins |
US4555490A (en) * | 1984-06-08 | 1985-11-26 | The United States Of America As Represented By The Department Of Health And Human Services | Rapid visualization system for gel electrophoresis |
US4703016A (en) * | 1986-05-05 | 1987-10-27 | The United States Of America As Represented By The Department Of Health And Human Services | Silver stain for rapid, quantitative detection of polypeptides and nucleic acids |
US4940659A (en) * | 1987-02-20 | 1990-07-10 | Monoclonetics International, Inc. | Screening extra-cellular body fluids for superoxide dismutase (SOD-1) for determining fetal trisomy 21 down syndrome |
US4892814A (en) * | 1987-06-22 | 1990-01-09 | The United States Of America As Represented By The Department Of Health And Human Services | Method for distinguishing Creutzfeldt-Jakob disease from other dementias |
US5817797A (en) * | 1988-06-01 | 1998-10-06 | The United States Of America As Represented By The Department Of Health And Human Services | Sequencing DNA; a modification of the polymerase chain reaction |
US5292665A (en) * | 1989-03-15 | 1994-03-08 | The United States Of America As Represented By The Department Of Health And Human Services | Catalyst for preparing polyacrylamide gel which improves the detection of biomaterials by silver staining |
US5844097A (en) * | 1990-11-30 | 1998-12-01 | Monoclonetics International, Inc. | Methods for the diagnosis of peripheral nerve damage |
ATE132269T1 (de) * | 1990-11-30 | 1996-01-15 | Monoclonetics Int | Verfahren zur diagnose chronischer niedriger rückenschmerzen und nackenschmerzen |
US5378602A (en) * | 1991-05-29 | 1995-01-03 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Highly informative microsatellite repeat polymorphic DNA markers twenty-[seven]six |
US5861504A (en) * | 1991-05-29 | 1999-01-19 | The United States Of America As Represented By The Department Of Health And Human Services | Eleven highly informative microsatelite repeat polymorphic DNA markers |
US5468610A (en) * | 1991-05-29 | 1995-11-21 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Three highly informative microsatellite repeat polymorphic DNA markers |
US5429947A (en) * | 1992-06-17 | 1995-07-04 | Merril; Carl R. | Diagnosing Alzheimer's disease and schizophrenia |
US5811093A (en) * | 1994-04-05 | 1998-09-22 | Exponential Biotherapies, Inc. | Bacteriophage genotypically modified to delay inactivations by the host defense system |
CA2186962A1 (en) * | 1994-04-05 | 1995-10-12 | Richard M. Carlton | Antibacterial therapy with genotypically modified bacteriophage |
US20010043924A1 (en) * | 1994-04-05 | 2001-11-22 | Exponential Biotherapies, Inc. | Antibacterial therapy with bacteriophage physico-chemically altered to delay inactivation by the host defense system |
US5736388A (en) * | 1994-12-30 | 1998-04-07 | Chada; Sunil | Bacteriophage-mediated gene transfer systems capable of transfecting eukaryotic cells |
SE506771C2 (sv) * | 1996-02-06 | 1998-02-09 | Gotpat 105 Ab | Fusionsprotein, bakteriofag uttryckande proteinet, dessas användning samt hybridoma celler och monoklonaler producerade av cellerna |
WO1998005344A1 (en) * | 1996-08-05 | 1998-02-12 | Brigham And Women's Hospital, Inc. | Bacteriophage-mediated gene therapy |
US20020177614A1 (en) * | 2001-03-23 | 2002-11-28 | Merril Carl R. | Methods for treating nuerodegenerative diseases including alzheimer's |
US7521479B2 (en) * | 2001-04-16 | 2009-04-21 | Panacea Pharmaceuticals, Inc. | Methods of treating prion disease in mammals |
WO2004041156A2 (en) * | 2002-01-23 | 2004-05-21 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health Andhuman Services | Method for determining sensitivity to a bacteriophage |
US7399753B2 (en) * | 2002-02-25 | 2008-07-15 | Virxsys Corporation | Trans-splicing mediated photodynamic therapy |
-
2001
- 2001-07-25 CA CA002417188A patent/CA2417188A1/en not_active Abandoned
- 2001-07-25 EP EP01955955A patent/EP1305038B1/de not_active Expired - Lifetime
- 2001-07-25 AU AU2001278003A patent/AU2001278003A1/en not_active Abandoned
- 2001-07-25 AT AT01955955T patent/ATE305793T1/de not_active IP Right Cessation
- 2001-07-25 DE DE60113851T patent/DE60113851T2/de not_active Expired - Lifetime
- 2001-07-25 ES ES01955955T patent/ES2252263T3/es not_active Expired - Lifetime
- 2001-07-25 WO PCT/US2001/023390 patent/WO2002007742A2/en active IP Right Grant
-
2003
- 2003-01-21 US US10/350,256 patent/US7163818B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1305038A2 (de) | 2003-05-02 |
WO2002007742A9 (en) | 2002-04-18 |
ES2252263T3 (es) | 2006-05-16 |
EP1305038B1 (de) | 2005-10-05 |
ATE305793T1 (de) | 2005-10-15 |
US7163818B2 (en) | 2007-01-16 |
DE60113851T2 (de) | 2006-07-20 |
DE60113851D1 (de) | 2006-02-16 |
CA2417188A1 (en) | 2002-01-31 |
US20030216338A1 (en) | 2003-11-20 |
WO2002007742A8 (en) | 2003-10-30 |
WO2002007742A3 (en) | 2002-08-08 |
WO2002007742A2 (en) | 2002-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001278003A1 (en) | Bacteriophage having multiple host range | |
AU2002328972A1 (en) | Piperidine derivatives as antibacterial agents | |
AU2003291227A1 (en) | Antibacterial agents | |
WO2003088897A3 (en) | Fab i inhibitors | |
AU2001239725A1 (en) | Antibacterial agents | |
EP1594444A3 (de) | Verfahren und zusammensetzungen zur behandlung und prävention von staphylokokkus- und anderen bakteriellen infektionen | |
GB0125222D0 (en) | Composition for the treatment of microbial infections | |
AU6339599A (en) | Quinoline derivatives and their use as antibacterial agents | |
WO2003099217A3 (en) | Methods of treating bacterial infections and diseases associated therewith | |
EP1560821B8 (de) | Antibakterielle wirkstoffe | |
EA200600280A1 (ru) | Композиции на основе производных липопептидных антибиотиков и способы их применения | |
AU2003901008A0 (en) | Composition for the treatment and prevention of bacterial infections | |
AU2005099A (en) | Methods and compositions for the treatment and prevention of (staphylococcus aureus) infections | |
AU2003245928A1 (en) | Antibacterial amide macrocycles | |
AU4652000A (en) | Fab i inhibitors | |
YU102503A (sh) | Kondenzovani pirimidinski dhfr inhibitori kao antibakterijska sredstva | |
AU2002232558A1 (en) | Compounds, compositions and methods for treatment of parasitic infections | |
WO2004041158A3 (en) | Rifalazil compositions and therapeutic regimens | |
AU2003294565A8 (en) | Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents | |
WO2003061704A3 (en) | Combination therapy for the treatment of bacterial infections | |
NZ509051A (en) | Chemotaxis-inhibiting protein of staphylococcus (CHIPS) and its use | |
AU2001265876A1 (en) | Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases | |
AU2002334761A1 (en) | Methods of treating drug-resistant bacterial infections | |
AU2003259159A1 (en) | N-aryl-2-oxazolidinones and their derivatives | |
AU2002303480A1 (en) | Glycopeptide antibiotics |